medigraphic.com
ISSN 1561-3070 (Electronic)

2020, Number 4

<< Back Next >>

Rev Cub Oftal 2020; 33 (4)

Baerveldt valve implantation in a case of refractory glaucoma

Chaviano LG, Arzuaga HE, Díaz ÁY, Pérez RY, Fumero GFY

Language: Spanish
References: 20
Page: 1-13
PDF size: 433.65 Kb.


ABSTRACT

A case is presented of a female 52-year-old patient with a history of bronchial asthma, myopia and juvenile glaucoma diagnosed at age 22. Two trabeculectomies were performed on the left eye and one on the right eye. In the year 2008 the patient underwent phacoemulsification surgery plus intraocular lens implantation in both eyes. She attended our service a year ago, reporting progressive vision reduction. Ophthalmological examination revealed best corrected visual acuity of 0.4 and intraocular pressure of 30 and 23.5 mm/Hg for either eye, with maximum tolerated hypotensive therapy. Funduscopy showed advanced glaucomatous damage, greater in the left eye. The treatment option selected was transcleral cyclophotocoagulation in two quadrants of the right eye. At 6 months intraocular pressure was 30 and 18 mm/Hg, and it was decided to implant a Baerveldt valve in the upper temporal quadrant of the right eye. Ophthalmological examination results at 7 days postoperative were intraocular pressure 5 mm/Hg, grade III athalamia and best corrected visual acuity 0.2. The treatment indicated was a cycloplegic mydriatic and topical and systemic anti-inflammatories. Ocular status improvement was achieved at 15 days. Satisfactory visual acuity and an intraocular pressure of 12 mm/Hg were obtained at 3 months postoperative. The Baerveldt drainage device is effective to achieve intraocular pressure reduction in refractory glaucoma.


REFERENCES

  1. American Academy of Ophtalmology. Glaucoma (Basic and clinical Science Course). SanFrancisco: American Academy of Ophtalmology; 2014.

  2. Gedde SJ, Schiffman JC, Feuer WJ, et al. Treatment outcomes in the Tube versusTrabeculectomy (TVT) Study after five years of follow-up. Am J Ophthalmol. 2012;153:789–803.

  3. Panos GC, Jeffrey WK, James CT, et al. The Ahmed versus Baerveldt study, five-yeartreatment outcomes. Ophthalmology. 2016;123(10):2093–102.

  4. Elbaklish KH, Saleh SM, Gomaa WA. Baerveldt Glaucoma Implant versus AhmedGlaucoma Implant in a One-Year Follow Up, Comparative Study. Clin Ophthalmol. 2020;14:29–39.

  5. Tseng VL, Coleman AL, Chang MY, Caprioli J. Aqueous shunts for glaucoma. CochrDatab Syst Rev. 2017;7:004918.

  6. Wang S, Gao X, Qian N. The Ahmed shunt versus the Baerveldt shunt for refractoryglaucoma: a meta-analysis. BMC Ophthalmol. 2016;16:83.

  7. Dave P, Senthil S, Choudhari N, Sekhar GC. Outcomes of Ahmed valve implant followinga failed initial trabeculotomy and trabeculectomy in refractory primary congenital glaucoma. Middle East Afr J Ophthalmol. 2015;22(1):64-8.

  8. Joshi AB, Parrish RK, Feuer WF. 2002 Survey of the American Glaucoma Society:practice preferences for glaucoma surgery and antifibrotic use. J Glaucoma. 2005;14(2):172-4.

  9. Barton K, Feuer WJ, Budenz DL, Schiffman J, Costa VP, Godfrey DG, Buys YM; AhmedBaerveldt Comparison Study Group. Three-year treatment outcomes in the Ahmed Baerveldt comparison study. Ophthalmology. 2014;121(8):1547-57.

  10. Wang YW, Wang PB, Zeng C, Xia XB. Comparison of the Ahmed glaucoma valve withthe Baerveldt glaucoma implant: a meta-analysis. BMC Ophthalmol. 2015;15:132.

  11. Budenz DL, Barton K, Gedde SJ, Feuer WJ, Schiffman J, Costa VP, Godfrey DG, BuysYM; Ahmed Baerveldt Comparison Study Group. Five-year treatment outcomes in the Ahmed Baerveldt comparison study. Ophthalmology. 2015;122(2):308-16.

  12. Budenz DL, Feuer WJ, Barton K, Schiffman J, Costa VP, Godfrey DG, Buys YM. AhmedBaerveldt Comparison Study Group. Postoperative complications in the Ahmed Baerveldt comparison study during five years of follow-up. Am J Ophthalmol. 2016;163:75-82.

  13. Namavari A, Hyde RA, Wang D, Vajaranant TS, Aref AA. Primary Baerveldt ShuntImplantation: Outcomes and Complications. Ophthalmology and Therapy; 2016,5(2):253-62.

  14. Lloyd MA, Sedlak T, Heuer DK, et al. Clinical experience with the single-plate Moltenoimplant in complicated glaucomas: update of a pilot study. Ophthalmology. 1992;99(5),679-87.

  15. Fellenbaum PS, Almeida AR, Minckler DS, Sidoti PA, Baerveldt G, Heuer DK. Krupindisc implantation for complicated glaucomas. Ophthalmology. 1994;10(1):1178-82.

  16. Kim EL, Tran J, Töteberg-Harms M, Chahal J, Rhee D, Chopra V, Francis B. VisionLoss and Recovery after Baerveldt Aqueous Tube Shunt Implantation. J Ophthalmol. 2017;7:1-12.

  17. Sharaawy T, Bhartiya S. Surgical Management of glaucoma: Evolving paradigms. Ind JOphthlamol: 2011;59(1):123-30.

  18. Salinas L, Chaudhary A, Berdahl JP, et al. Goniotomy using the Kahook dual blade insevere and refractory glaucoma: 6-month outcomes. J Glauc. 2018;27(10):849–55.

  19. Grover DS, Godfrey DG, Smith O, et al. Outcomes of gonioscopy-assisted transluminaltrabeculotomy (GATT) in eyes with prior incisional glaucoma surgery. J Glauc. 2017;26(1):41–5.

  20. Grover DS, Flynn WJ, Bashford KP, et al. Performance and safety of a new ab internogelatin stent in refractory glaucoma at 12 months. Am J Ophthalmol. 2017;183:25–36.




2020     |     www.medigraphic.com